Ebvb - The European Biotech Venture Builder

the european biotech venture builder (ebvb) works towards the purpose of democratizing drug development. the ebvb aims to improve the current status quo of drug development by implementing their integrated business model, designed to decrease risk while delivering higher valuations and impact biotech products: 1. at the european biotech venture builder, we make sure that leaders think, from the beginning, about how to maximise their innovations for success in global markets. competitiveness begins with identifying a robust value proposition, defining areas to win by scaling up, and considering how to differentiate products enough from competition to successfully gain access to the global market. 2. at the european biotech venture builder we ensure that strategies related to attracting and deploying of funds are considered from the beginning. this robust planning includes avoiding early dilution of company ownership, increasing company credibility through an optimized capital invest